Publications by authors named "David Ribes"

Claim this Profile
F
First Report of Daratumumab Therapy in Refractory THSD7A-Positive Membranous Nephropathy.
David Ribes, Stanislas Faguer

Kidney Int Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avacopan or Glucocorticoids for Severe Antineutrophil Cytoplasmic Autoantibody-Associated Rapidly Progressive Glomerulonephritis.
Stanislas Faguer, Charlotte Gabilan, Magali Colombat, Alexis Cassard, Clément Kounde, David Ribes

Kidney Int Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational universalism, or, Attending to relationalities at scale.
Francis Lee, David Ribes

Soc Stud Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome.
Júlia Weisinger, Raïda Bouzid, Jehane Fadlallah, François Provôt, Pascale Poullin, David Ribes

Lupus Sci Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added value of coupling anti-dsDNA and anti-chromatin antibodies in follow-up monitoring of systemic lupus erythematosus patients.
Caroline Carlé, Françoise Fortenfant, Chloé Bost, Julie Belliere, Stanislas Faguer, David Ribes

J Transl Autoimmun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing drinking water safety: Real-time prediction of trihalomethanes in a water distribution system using machine learning and multisensory technology.
Antonio J Aragón-Barroso, David Ribes, Francisco Osorio

Ecotoxicol Environ Saf· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avacopan for anti-neutrophil cytoplasm antibodies-associated vasculitis: a multicentre real-world study.
Charlotte Gabilan, Julie Belliere, Olivier Moranne, Pierre Pfirmann, Maxime Samson, David Ribes

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Philipp Gauckler, Anna Matyjek, Seleni Kapsia, Smaragdi Marinaki, Luis F Quintana, David Ribes

J Am Soc Nephrol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD163 detection in immune check-point inhibitors-related acute interstitial nephritis.
Thomas Perier, Yves Renaudineau, Juliette Pellegrini, Magali Colombat, Angie Arango Ramirez, David Ribes

Clin Kidney J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura.
Éloïse Colliou, Agnès Ribes, Clotilde Gaible, Mathilde Marlas, David Ribes

Res Pract Thromb Haemost· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary soluble CD163 is useful as "liquid biopsy" marker in lupus nephritis at both diagnosis and follow-up to predict impending flares.
Yves Renaudineau, Dominique Chauveau, Stanislas Faguer, Antoine Huart, David Ribes

J Transl Autoimmun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are serum C3 levels or kidney C3 deposits useful markers for predicting outcomes in patients with ANCA-associated vasculitis?
Alexis Cassard, Clément Kounde, Laurence Bouillet, Tiphaine Goulenok, David Ribes

J Transl Autoimmun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell-directed therapy for rituximab-refractory PLA2R+ membranous nephropathy.
Sofiane Salhi, David Ribes, Françoise Fortenfant, Stanislas Faguer

Nephrol Dial Transplant· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN.
Marie Sophie Meuleman, Paula Vieira-Martins, Carine El Sissy, Vincent Audard, Véronique Baudouin, David Ribes

Clin J Am Soc Nephrol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors.
Rayane Benyahia, Helene Lazareth, Adrien Flahault, Vesna Brglez, Barbara Seitz-Polski, David Ribes

Kidney Int Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy.
Sophie Chauvet, Jill J Hauer, Florent Petitprez, Marion Rabant, Paula Vieira Martins, David Ribes

Kidney Int· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
Manon Martins, Frank Bridoux, Jean Michel Goujon, Marie Sophie Meuleman, David Ribes

Am J Kidney Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of a paroxysmal nocturnal hemoglobinuria clone in an essential thrombocythemia: a link between and .
Alexej Knaus, François Vergez, Cédric Garcia, Hartmut Engels, Hela Hundertmark, David Ribes, Agnes Ribes

Haematologica· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact and prognosis of cryoglobulinemia and cryofibrinogenemia in systemic sclerosis.
Sébastien De Almeida Chaves, Bénédicte Puissant, Tiphaine Porel, Eva Bories, Daniel Adoue, David Ribes

Autoimmun Rev· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sedimentary legacy and the disturbing recurrence of the human in long-term ecological research.
Shana Lee Hirsch, David Ribes, Sarah Inman

Soc Stud Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option.
Charlotte Gabilan, Pierre Pfirmann, David Ribes, Claire Rigothier, Dominique Chauveau

Kidney Int Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up and Immunomonitoring of Relapsing Type 1 Autoimmune Pancreatitis Treated With Rituximab.
Guillaume Le Cosquer, David Ribes, Stanislas Faguer, Muriel Jeune, Laurent Alric

Pancreas· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination.
Adrien Picod, Jean-Michel Rebibou, Antoine Dossier, Bérengère Cador, David Ribes

Blood· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum of Kidney Disorders Associated with T-Cell Immunoclones.
Alexis Piedrafita, François Vergez, Julie Belliere, Nais Prades, Magali Colombat, David Ribes

J Clin Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review.
Maxime Dauvergne, David Buob, Cédric Rafat, Marie-Flore Hennino, Mathilde Lemoine, David Ribes

Clin Kidney J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis